JENNIFER JONES: Open Payments
NPI 1407365265 · JESUP, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 46 payments from 15 companies in 2025. Trend: 2023 $1,130 · 2024 $1,297 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| PFIZER INC. | 6 | $89 |
| Medline Industries LP | 2 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Novo Nordisk Inc | 4 | $61 |
| Amgen Inc. | 4 | $59 |
| Lilly USA, LLC | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, OTEZLA, NURTEC ODT, REXULTI, JARDIANCE, FARXIGA.
Industry payments across GA — which companies pay providers there.
